マーケットレポート詳細
ゲノム編集：技術および世界市場2027年予測
Genome Editing: Technologies and Global Markets
- 出版元：BCC Research
出版元について - 発行年：2022年5月
- 定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文137ページになります。
- 商品コード：BCC410
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
ゲノム編集の世界市場規模は、2022年段階の43億ドルから、2027年には128億ドルへと急速な拡大が予測されます。同市場の2022-2027年の平均年成長率(CAGR)は24.7%と推計されます。
当レポートでは、ゲノム編集の市場/技術的背景、各種セグメント別市場分析(技術別、用途別、エンドユーザー別、国地域別)、競合状況、COVID-19の影響、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
◆イントロダクション
・調査目的
・調査対象
・調査手法
◆サマリーと調査ハイライト
◆最近のゲノム編集技術
・ゲノム編集の歴史
・ゲノム編集技術の比較
・CRISPR-Cas9の発見
・CRISPR-Cas9システムのコンポーネント
・CRISPR-Cas9の仕組み
・CRISPR-Cas9システムの利点
・CRISPRゲノム編集の評判
・主な技術課題
・新ゲノム編集システム：CRISPR-Cpf1
・ゲノム編集を用いた疾患治療に関する研究
・ゲノム編集の影響
・ゲノム編集の今後
◆ゲノム編集の用途
・イントロダクション
・医薬品の発見/開発
・臨床療法
・非遺伝子組み換え育種
・診断
・その他
◆特許及び出版物の分析
・特許分析
・出版物分析
◆技術別、市場
・CRISPR-Cas技術
・TALEN
・ZFN
・その他
※市場予測データ掲載-2027年
※技術別に地域別の細分化データ掲載
◆用途別、市場
・医薬品開発
・植物育種
・診断
・臨床療法
・その他
※市場予測データ掲載-2027年
※用途別に地域別の細分化データ掲載
◆エンドユーザー別、市場
・バイオテクノロジー/製薬企業
・農業バイオテクノロジー企業
・研究機関
・その他
※市場予測データ掲載-2027年
※エンドユーザー別に地域別の細分化データ掲載
◆地域別、市場
・米国
欧州
・ドイツ、英国、フランス
・その他欧州
アジア太平洋
・日本、中国、オーストラリア
・その他アジア太平洋
その他地域
※地域別に全セグメント別の細分化データ掲載、詳細は目次参照
※地域別に主要国別の細分化データ掲載
◆競合状況
・概要
・成長戦略
◆ゲノム編集市場に影響を与える要因
・市場の成長要因
・市場の成長を制限する要因
◆COVID-19の影響
◆ゲノム編集市場の主要企業プロフィール
・ALDEVRON
・ALLELE BIOTECHNOLOGY
・AMERICAN TYPE CULTURE COLLECTION (ATCC)
・APPLIED STEMCELL INC.
・ARBOR BIOTECHNOLOGIES INC.
・ATUM (DNA2.0)
・AUSTRALIAN BIORESOURCES LTD.
・AXOL BIOSCIENCE LTD.
・BEAM THERAPEUTICS
・BIOCYTOGEN
・BIO-RAD LABORATORIES INC.
・BIOTOOLS CO. LTD.
・BLUEBIRD BIO
・BIO-TECHNE
・CALYXT INC.
・CANOPY BIOSCIENCES
・CARIBOU BIOSCIENCES INC.
・CRISPR THERAPEUTICS
・EDITAS MEDICINE
・GENECOPOEIA
・GENEWIZ
・GENSCRIPT
・HERA BIOLABS
・HORIZON DISCOVERY
・INTELLIA THERAPEUTICS INC.
・INTEGRATED DNA TECHNOLOGIES
・JUNO THERAPEUTICS
・LONZA
・MAMMOTH BIOSCIENCES
・MERCK KGAA (SIGMA-ALDRICH)
・ORIGENE TECHNOLOGIES
・PRECISION BIOSCIENCES INC.
・RECOMBINETICS
・REGENERON PHARMACEUTALS INC.
・SANGAMO BIOSCIENCES
・SYNTHEGO
・SYSTEM BIOSCIENCES
・TAKARA BIO USA INC.
・THERMO FISHER SCIENTIFIC INC.
・TOOLGEN INC.
・VERTEX PHARMACEUTICALS INC.
（全137頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Intended Audience
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Highlights of the Market for Genome Editing
Chapter 3 Current Genome-Editing Technologies
Overview
History of Genome Editing
Comparison of Genome Editing Technologies
Discovery of CRISPR-Cas9
Components of CRISPR-Cas Systems
- SgRNA
- Cas9 Nucleases
How CRISPR-Cas Works
Advantage of the CRISPR-Cas9 System
Popularity of CRISPR Genome Editing
Major Technological Issues
- Efficiency
- Specificity/Off-Target Effect
- Delivery Systems
- Immunogenicity Risk for Clinical Applications
A New Genome-Editing System: CRISPR-Cpf1
Studies on Treating Diseases Using Genome Editing
Impact of Genome Editing
Future of CRISPR
Chapter 4 Applications of Genome Editing
Introduction
Drug Discovery and Development
Clinical Therapy
Non-transgenic Breeding
Diagnostics
Other Applications
Chapter 5 Patents and Publication Analysis
Patent Analysis
Publication Analysis
Chapter 6 Market Breakdown by Technology
Market Overview
Market Share and Forecast
- Technology
- TALEN
- ZFN
- Other Technologies
Chapter 7 Market Breakdown by Application
Market Overview
Market Share and Forecast
- Drug Development
- Plant Breeding
- Diagnostics
- Clinical Therapy
- Others
Chapter 8 Market Breakdown by End User
Market Overview
Market Share and Forecast
- Biotechnology and Pharmaceutical Companies
- Agricultural Biotechnology Companies
- Research Institutions
- Others
Chapter 9 Market Breakdown by Region
Global Market for Genome Editing by Region
- United States
Europe
- Germany
- United Kingdom
- France
- Rest of Europe
Asia-Pacific
- China
- Australia
- Japan
- Rest of Asia-Pacific
Rest of the World
Chapter 10 Competitive Landscape
Overview
Growth Strategies
- Licensing and Agreements
- Collaborations with Big Biopharmaceutical Companies
- In-House R&D Program
- Mergers and Acquisitions
- Venture Capital Funding
Chapter 11 Factors Influencing the Genome Editing Market
Driving Forces
- New Genome-Editing Technologies and Applications
- Need for Precision Medicine
- Increasing Applications in Synthetic Biology and Drug Discovery
- Investments from Both Public and Private Sectors
- High Prevalence of Genetic Disorders
- Applications in Plant and Livestock Breeding
Factors Limiting Market Growth
- Stringent Regulatory Frameworks and Time-Consuming Approval Processes
- Patent Disputes
- Governmental Policies and Regulations
- Regulatory Uncertainty on Genome-Edited Crops
- Ethical Issues
Chapter 12 Impact of COVID-19 on the Genome Editing Market
Introduction
Chapter 13 Company Profiles
ALDEVRON
ALLELE BIOTECHNOLOGY
AMERICAN TYPE CULTURE COLLECTION (ATCC)
APPLIED STEMCELL INC.
ARBOR BIOTECHNOLOGIES INC.
ATUM (DNA2.0)
AUSTRALIAN BIORESOURCES LTD.
AXOL BIOSCIENCE LTD.
BEAM THERAPEUTICS
BIOCYTOGEN
BIO-RAD LABORATORIES INC.
BIOTOOLS CO. LTD.
BLUEBIRD BIO
BIO-TECHNE
CALYXT INC.
CANOPY BIOSCIENCES
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
EDITAS MEDICINE
GENECOPOEIA
GENEWIZ
GENSCRIPT
HERA BIOLABS
HORIZON DISCOVERY
INTELLIA THERAPEUTICS INC.
INTEGRATED DNA TECHNOLOGIES
JUNO THERAPEUTICS
LONZA
MAMMOTH BIOSCIENCES
MERCK KGAA (SIGMA-ALDRICH)
ORIGENE TECHNOLOGIES
PRECISION BIOSCIENCES INC.
RECOMBINETICS
REGENERON PHARMACEUTALS INC.
SANGAMO BIOSCIENCES
SYNTHEGO
SYSTEM BIOSCIENCES
TAKARA BIO USA INC.
THERMO FISHER SCIENTIFIC INC.
TOOLGEN INC.
VERTEX PHARMACEUTICALS INC.
List of Tables
Summary Table : Global Market for Genome Editing, by Technology Type, Through 2027
Table 1 : Comparison of Genome Editing Technologies
Table 2 : Global Market for Genome Editing, by Technology Type, Through 2027
Table 3 : Global Market for CRISPR-Cas, by Region, Through 2027
Table 4 : Global Market for TALEN, by Region, Through 2027
Table 5 : Global Market for ZFN, by Region, Through 2027
Table 6 : Global Market for Other Genome-Editing Technologies, by Region, Through 2027
Table 7 : Global Market for Genome Editing, by Application, Through 2027
Table 8 : Global Market for Genome Editing in Drug Development, by Region, Through 2027
Table 9 : Global Market for Genome Editing for Plant Breeding, by Region, Through 2027
Table 10 : Global Market for Genome Editing in Diagnostics, by Region, Through 2027
Table 11 : Global Market for Genome Editing in Clinical Therapy, by Region, Through 2027
Table 12 : Global Market for Genome Editing in Other Applications, by Region, Through 2027
Table 13 : Global Market for Genome Editing, by End User, Through 2027
Table 14 : Global Market for Genome Editing for Biotechnology and Pharmaceutical Companies, by Region, Through 2027
Table 15 : Global Market for Genome Editing for Agricultural Biotechnology Companies, by Region, Through 2027
Table 16 : Companies Licensing Genome Editing Technologies from Research Institutions
Table 17 : Global Market for Genome Editing for Research Institutions, by Region, Through 2027
Table 18 : Global Market for Genome Editing for Other End Users, by Region, Through 2027
Table 19 : Global Market for Genome Editing, by Region, Through 2027
Table 20 : European Market for Genome Editing, by Country, Through 2027
Table 21 : Asia-Pacific Market for Genome Editing, by Country, Through 2027
Table 22 : Arbor Biotechnologies Inc.: Recent Developments
Table 23 : Bio-Rad Laboratories Inc.: Recent Developments
Table 24 : Bluebird Bio Inc.: Product Portfolio
Table 25 : Calyxt Inc.: Key Developments
Table 26 : Caribou Biosciences Inc.: Key Developments
Table 27 : CRISPR Therapeutics: Recent Developments
Table 28 : Horizon Company Ltd.: Key Developments
Table 29 : Intellia Therapeutics: Key Developments
Table 30 : Mammoth Biosciences: Key Developments
Table 31 : Precision Biosciences Inc.: Key Developments
Table 32 : Sangamo Biosciences: Key Developments
Table 33 : Thermo Fisher Scientific Inc.: Key Developments
Table 34 : Vertex Pharmaceuticals Inc.: Key Developments"
List of Figures
Summary Figure : Global Market for Genome Editing, by Technology Type, 2020-2027
Figure 1 : Applications of Genome Editing
Figure 2 : Genome-Editing Patent Applications, by Major Universities at WIPO, 2018-2021
Figure 3 : Genome Editing Publications Shares, by Technology Type, 2021
Figure 4 : CRISPR Publications, by Year, 2018-2021
Figure 5 : ZFN Publications, by Year, 2018-2021
Figure 6 : TALENS Publications, by Year, 2018-2021
Figure 7 : Global Market Shares of Genome Editing, by Technology Type, 2021
Figure 8 : Global Market for CRISPR-Cas, 2020-2027
Figure 9 : Global Market for TALEN, 2020-2027
Figure 10 : Global Market for ZFN, 2020-2027
Figure 11 : Global Market for Other Genome-Editing Technologies, 2020-2027
Figure 12 : Global Market Shares of Genome Editing, by Application, 2021
Figure 13 : Global Market for Genome Editing in Drug Development, 2020-2027
Figure 14 : Global Market for Genome Editing for Plant Breeding, 2020-2027
Figure 15 : Global Genome-Editing Market in Diagnostics, 2020-2027
Figure 16 : Global Market for Genome Editing in Clinical Therapy, 2020-2027
Figure 17 : Global Market for Genome Editing in Other Applications, 2020-2027
Figure 18 : Global Market Shares of Genome Editing, by End User, 2021
Figure 19 : Global Market for Genome Editing for Biotechnology and Pharmaceutical Companies, 2020-2027
Figure 20 : Global Market for Genome Editing for Agricultural Biotechnology Companies, 2020-2027
Figure 21 : Global Market for Genome Editing for Research Institutions, 2020-2027
Figure 22 : Global Market for Genome Editing for Other End Users, 2020-2027
Figure 23 : Global Market Shares of Genome Editing, by Region, 2021
Figure 24 : U.S. Market for Genome Editing, 2020-2027
Figure 25 : European Market Shares of Genome Editing, by Country, 2021
Figure 26 : German Market for Genome Editing, 2020-2027
Figure 27 : U.K. Market for Genome Editing, 2020-2027
Figure 28 : French Market for Genome Editing, 2020-2027
Figure 29 : Rest of European Market for Genome Editing, 2020-2027
Figure 30 : Asia-Pacific Market Shares of Genome Editing, by Country, 2021
Figure 31 : Chinese Market for Genome Editing, 2020-2027
Figure 32 : Australian Market for Genome Editing, 2020-2027
Figure 33 : Japanese Market for Genome Editing, 2020-2027
Figure 34 : Rest of Asia-Pacific Market for Genome Editing, 2020-2027
Figure 35 : RoW Market for Genome Editing, 2020-2027
Figure 36 : Bio-Rad Laboratories Inc.: Annual Revenue, 2018-2020
Figure 37 : Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2020
Figure 38 : Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2020
Figure 39 : Caribou Biosciences Inc.: Annual Revenue, 2019-2021
Figure 40 : Editas Medicine: Annual Revenue, 2020 and 2021
Figure 41 : Horizon Discovery Ltd., Annual Revenue, 2018 and 2019
Figure 42 : Intellia Therapeutics: Annual Revenue, 2020 and 2021
Figure 43 : Sangamo Biosciences: Annual Revenue, 2019-2021
Figure 44 : Thermo Fisher Scientific Inc.: Annual Revenue, 2019-2021
Figure 45 : Thermo Fisher Scientific Inc.: Market Share, by Region, 2021
Figure 46 : Thermo Fisher Scientific Inc.: Market Share, by Business Segments, 2021
Figure 47 : Thermo Fisher Scientific Inc.: Market Share, by Products, 2021
Figure 48 : Vertex Pharmaceuticals Inc.: Annual Revenue, 2020 and 2021
Figure 49 : Vertex Pharmaceuticals Inc.: Market Share, by Region, 2020